Total Payments
$416,964
2024 Payments
$122,137
Companies
37
Transactions
1,254
Medicare Patients
1,706
Medicare Billing
$753,828
Payment Breakdown by Category
Other$330,659 (79.3%)
Consulting$35,250 (8.5%)
Travel$28,371 (6.8%)
Food & Beverage$22,087 (5.3%)
Education$596.39 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $329,309 | 167 | 79.0% |
| Consulting Fee | $35,250 | 13 | 8.5% |
| Travel and Lodging | $28,371 | 138 | 6.8% |
| Food and Beverage | $22,087 | 919 | 5.3% |
| Honoraria | $1,350 | 1 | 0.3% |
| Education | $596.39 | 16 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $118,278 | 224 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $93,705 | 165 | $0 (2024) |
| ABBVIE INC. | $84,752 | 172 | $0 (2024) |
| Axsome Therapeutics, Inc. | $39,046 | 47 | $0 (2024) |
| Allergan, Inc. | $25,287 | 126 | $0 (2020) |
| Takeda Pharmaceuticals U.S.A., Inc. | $18,677 | 84 | $0 (2024) |
| Alkermes, Inc. | $16,052 | 42 | $0 (2024) |
| Takeda Pharmaceuticals America, Inc. | $13,296 | 15 | $0 (2017) |
| Teva Pharmaceuticals USA, Inc. | $1,377 | 81 | $0 (2024) |
| Lundbeck LLC | $1,020 | 61 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $122,137 | 223 | ABBVIE INC. ($40,565) |
| 2023 | $100,107 | 198 | AbbVie Inc. ($34,261) |
| 2022 | $39,372 | 146 | Janssen Pharmaceuticals, Inc ($22,734) |
| 2021 | $21,582 | 143 | Janssen Pharmaceuticals, Inc ($11,978) |
| 2020 | $10,559 | 97 | Otsuka America Pharmaceutical, Inc. ($7,719) |
| 2019 | $33,513 | 152 | Otsuka America Pharmaceutical, Inc. ($14,462) |
| 2018 | $48,408 | 168 | Otsuka America Pharmaceutical, Inc. ($29,913) |
| 2017 | $41,285 | 127 | Otsuka America Pharmaceutical, Inc. ($20,505) |
All Payment Transactions
1,254 individual payment records from CMS Open Payments — Page 1 of 51
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: ADHD | ||||||
| 12/17/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $5.91 | General |
| Category: CNS | ||||||
| 12/16/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/16/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Travel and Lodging | Cash or cash equivalent | $76.38 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/11/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,060.00 | General |
| Category: CNS | ||||||
| 12/11/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $6.59 | General |
| Category: PSYCHIATRY | ||||||
| 12/10/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Neuropsychiatry | ||||||
| 12/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.00 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: Neuropsychiatry | ||||||
| 11/19/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: PSYCHIATRY | ||||||
| 11/05/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/05/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Travel and Lodging | In-kind items and services | $127.30 | General |
| Category: CNS | ||||||
| 11/05/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $25.32 | General |
| Category: PSYCHIATRY | ||||||
| 11/01/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Travel and Lodging | Cash or cash equivalent | $70.35 | General |
| Category: PSYCHIATRY | ||||||
| 10/29/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $130.00 | General |
| Category: CNS | ||||||
| 10/26/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Travel and Lodging | Cash or cash equivalent | $87.10 | General |
| Category: PSYCHIATRY | ||||||
| 10/24/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,417.00 | General |
| Category: PSYCHIATRY | ||||||
| 10/24/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $23.56 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/22/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,750.00 | General |
| Category: Neuroscience | ||||||
| 10/22/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $18.04 | General |
| Category: PSYCHIATRY | ||||||
| 10/17/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $25.32 | General |
| Category: PSYCHIATRY | ||||||
| 10/16/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $166.07 | General |
| Category: Neuroscience | ||||||
| 10/10/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/10/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Travel and Lodging | Cash or cash equivalent | $127.30 | General |
| Category: Psychology/Psychiatric | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 393 | 1,871 | $502,330 | $193,046 |
| 2022 | 10 | 465 | 2,290 | $624,587 | $238,691 |
| 2021 | 9 | 432 | 2,016 | $580,316 | $219,460 |
| 2020 | 8 | 416 | 1,234 | $322,056 | $102,631 |
Total Patients
1,706
Total Services
7,411
Medicare Billing
$753,828
Procedure Codes
35
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90868 | Treatment using magnetic field to stimulate nerve cells in brain, subsequent delivery and management | Office | 2023 | 24 | 728 | $254,800 | $95,444 | 37.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 242 | 957 | $200,490 | $78,716 | 39.3% |
| 90837 | Psychotherapy, 1 hour | Office | 2023 | 36 | 80 | $20,800 | $7,878 | 37.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 25 | 32 | $8,000 | $3,875 | 48.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $5,640 | $2,074 | 36.8% |
| 90791 | Psychiatric diagnostic evaluation | Office | 2023 | 18 | 18 | $5,400 | $1,999 | 37.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 12 | 12 | $4,200 | $1,763 | 42.0% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 17 | 25 | $3,000 | $1,297 | 43.2% |
| 90868 | Treatment using magnetic field to stimulate nerve cells in brain, subsequent delivery and management | Office | 2022 | 38 | 1,001 | $350,350 | $130,746 | 37.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 263 | 924 | $193,512 | $75,478 | 39.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 14 | 73 | $18,250 | $9,717 | 53.2% |
| 90837 | Psychotherapy, 1 hour | Office | 2022 | 29 | 82 | $21,210 | $8,372 | 39.5% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 29 | 98 | $11,760 | $4,973 | 42.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 30 | 30 | $8,880 | $3,083 | 34.7% |
| 90867 | Treatment using magnetic field to stimulate nerve cells in brain, initial delivery and management | Office | 2022 | 16 | 17 | $9,350 | $2,534 | 27.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 17 | 17 | $5,950 | $1,841 | 30.9% |
| 90791 | Psychiatric diagnostic evaluation | Office | 2022 | 15 | 15 | $4,500 | $1,836 | 40.8% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2022 | 14 | 33 | $825.00 | $110.08 | 13.3% |
| 90868 | Transcranial magnetic stimulation treatment (stimulates nerve cells in brain to improve symptoms of depression), subsequent delivery and management, per session | Office | 2021 | 38 | 1,064 | $372,400 | $139,005 | 37.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 232 | 698 | $146,196 | $57,563 | 39.4% |
| 90837 | Psychotherapy, 60 minutes | Office | 2021 | 33 | 63 | $16,050 | $7,046 | 43.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 29 | 30 | $8,940 | $3,052 | 34.1% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 20 | 53 | $6,360 | $2,879 | 45.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 31 | 59 | $10,620 | $2,799 | 26.4% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 16 | 16 | $5,600 | $2,785 | 49.7% |
About Dr. Daniel Thistlethwaite, MD
Dr. Daniel Thistlethwaite, MD is a Psychiatry healthcare provider based in South Charleston, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/22/2007. The National Provider Identifier (NPI) number assigned to this provider is 1518083328.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Thistlethwaite, MD has received a total of $416,964 in payments from pharmaceutical and medical device companies, with $122,137 received in 2024. These payments were reported across 1,254 transactions from 37 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($329,309).
As a Medicare-enrolled provider, Thistlethwaite has provided services to 1,706 Medicare beneficiaries, totaling 7,411 services with total Medicare billing of $753,828. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Other Specialties Psychiatry
- Location South Charleston, WV
- Active Since 03/22/2007
- Last Updated 06/25/2025
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1518083328
Products in Payments
- REXULTI (Drug) $118,894
- VRAYLAR (Drug) $109,962
- SPRAVATO (Drug) $93,525
- Auvelity (Drug) $38,964
- Trintellix (Drug) $31,267
- LYBALVI (Drug) $15,694
- LATUDA (Drug) $864.56
- AUSTEDO (Drug) $760.12
- TRINTELLIX (Drug) $703.38
- WAKIX (Drug) $404.38
- CAPLYTA (Drug) $401.52
- Wakix (Drug) $349.12
- Azstarys (Drug) $320.19
- ARISTADA (Drug) $319.44
- VYVANSE (Drug) $299.41
- BrainsWay Deep TMS (Device) $297.10
- Brainsway Deep TMS (Device) $286.69
- Austedo XR (Drug) $271.93
- Adzenys XR-ODT (Drug) $258.29
- BRINTELLIX (Drug) $229.88
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in South Charleston
Russell Voltin, M.d, M.D
Psychiatry — Payments: $58,135
Psychiatry $58,135
Hussein El-Khatib, Md, MD
Psychiatry — Payments: $20,779
Psychiatry $20,779
Amy Wehrle, Do, DO
Psychiatry — Payments: $9,439
Psychiatry $9,439
Dr. Alexander Otellin, Md, MD
Psychiatry — Payments: $5,351
Psychiatry $5,351
John Hutton, M.d, M.D
Psychiatry — Payments: $220.10
Psychiatry $220.10
Dr. Tara Ray, Do, DO
Psychiatry — Payments: $29.99
Psychiatry $29.99